Xilio Therapeutics (XLO) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Xilio Therapeutics (XLO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 13M (-7.60%) | 14M (-28.21%) | 19M (+136.01%) | 8.08M (+175.77%) | 2.93M (+70.35%) | 1.72M (-23.89%) | 2.26M (-4.24%) | 2.36M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 20M (+9.44%) | 18M (+26.54%) | 14M (-6.59%) | 15M (+85.37%) | 8.27M (-6.45%) | 8.84M (-17.84%) | 11M (-4.10%) | 11M (+7.88%) | 10M (-11.41%) | 12M (+6.24%) | 11M (-16.41%) | 13M (-18.04%) | 16M (+7.53%) | 15M (+15.03%) | 13M (-19.75%) | 16M (+8.91%) | 15M (+31.45%) | 11M (+8.40%) | 10M (-41.01%) | 18M (+52.75%) | 12M (-64.19%) | 32M (+183.16%) | 11M | - | - |
Selling General And Administrative | 6.93M (-6.35%) | 7.40M (+10.94%) | 6.67M (-6.32%) | 7.12M (-16.43%) | 8.52M (+30.67%) | 6.52M (+3.33%) | 6.31M (+8.42%) | 5.82M (-5.21%) | 6.14M (-3.91%) | 6.39M (+1.27%) | 6.31M (-8.55%) | 6.90M (-6.76%) | 7.40M (-9.42%) | 8.17M (+13.95%) | 7.17M (-13.72%) | 8.31M (+31.90%) | 6.30M (-23.17%) | 8.20M (+49.36%) | 5.49M (+4.37%) | 5.26M (+7.35%) | 4.90M (-34.58%) | 7.49M (+137.03%) | 3.16M | - | - |
Operating Expenses | 27M (+4.86%) | 26M (+21.52%) | 21M (-6.46%) | 22M (+33.79%) | 17M (+9.32%) | 15M (-9.81%) | 17M (-0.23%) | 17M (-2.46%) | 17M (-3.53%) | 18M (+4.44%) | 17M (-13.72%) | 20M (-14.49%) | 24M (+1.55%) | 23M (+14.65%) | 20M (-17.68%) | 25M (+15.69%) | 21M (+8.49%) | 20M (+22.56%) | 16M (-30.64%) | 23M (+39.29%) | 17M (-58.64%) | 40M (+173.19%) | 15M | - | - |
Depreciation And Amortization | 340K (-54.05%) | 740K (+146.67%) | 300K | - | 500K (-37.50%) | 800K (+100.00%) | 400K | - | 440K (-68.57%) | 1.40M | - | - | 500K (-64.54%) | 1.41M | - | - | 440K (-61.74%) | 1.15M | - | - | 350K (-67.29%) | 1.07M | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -14.11M (+19.17%) | -11.84M (+513.47%) | -1.93M (-86.57%) | -14.37M (+3.75%) | -13.85M (+1.61%) | -13.63M (-7.66%) | -14.76M (+0.41%) | -14.70M (-15.95%) | -17.49M (-3.53%) | -18.13M (+4.44%) | -17.36M (-13.72%) | -20.12M (-14.49%) | -23.53M (+1.55%) | -23.17M (+14.65%) | -20.21M (-17.68%) | -24.55M (+15.69%) | -21.22M (+8.49%) | -19.56M (+22.56%) | -15.96M (-30.64%) | -23.01M (+39.29%) | -16.52M (-58.64%) | -39.94M (+173.19%) | -14.62M | - | - |
Ebit | -14.11M (+19.17%) | -11.84M (+513.47%) | -1.93M (-86.57%) | -14.37M (+3.75%) | -13.85M (+1.61%) | -13.63M (-7.66%) | -14.76M (+0.41%) | -14.70M (-15.95%) | -17.49M (-3.53%) | -18.13M (+4.44%) | -17.36M (-13.72%) | -20.12M (-14.49%) | -23.53M (+1.55%) | -23.17M (+14.65%) | -20.21M (-17.68%) | -24.55M (+15.69%) | -21.22M (+8.49%) | -19.56M (+22.56%) | -15.96M (-30.64%) | -23.01M (+39.29%) | -16.52M (-18.66%) | -20.31M (+38.92%) | -14.62M (+27.02%) | -11.51M (+41.75%) | -8.12M |
EBITDA | -13.77M (+43.29%) | -9.61M (+489.57%) | -1.63M (-89.71%) | -15.84M (+18.65%) | -13.35M (-1.91%) | -13.61M (-5.22%) | -14.36M (+3.16%) | -13.92M (-18.31%) | -17.04M (-5.86%) | -18.10M (+8.06%) | -16.75M (-13.44%) | -19.35M (-15.98%) | -23.03M (+4.16%) | -22.11M (+11.72%) | -19.79M (-19.59%) | -24.61M (+18.43%) | -20.78M (+15.83%) | -17.94M (+10.40%) | -16.25M (-29.90%) | -23.18M (+43.35%) | -16.17M (-15.12%) | -19.05M (+28.54%) | -14.82M (+28.76%) | -11.51M (+41.75%) | -8.12M |
Other Income / Expenses | |||||||||||||||||||||||||
Other Non Operating Income | 1.28M (+16.36%) | 1.10M (+7.84%) | 1.02M | -1.43M | 590K (-74.79%) | 2.34M (+216.22%) | 740K (-5.13%) | 780K (+178.57%) | 280K (-89.74%) | 2.73M (+347.54%) | 610K (-19.74%) | 760K (-13.64%) | 880K (-5.38%) | 930K (+121.43%) | 420K | -60.00K (-53.85%) | -130.00K (-82.89%) | -760.00K (+162.07%) | -290.00K (+70.59%) | -170.00K (+13.33%) | -150.00K (-77.27%) | -660.00K (+230.00%) | -200.00K | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -35.04M | - | - | - | -58.24M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -9.53M | 10M | -16.29M (+2.84%) | -15.84M (+19.46%) | -13.26M (+1.30%) | -13.09M (-6.63%) | -14.02M (+0.72%) | -13.92M (-19.07%) | -17.20M (-2.55%) | -17.65M (+5.37%) | -16.75M (-13.44%) | -19.35M (-14.57%) | -22.65M (+0.80%) | -22.47M (+13.54%) | -19.79M (-19.59%) | -24.61M (+15.27%) | -21.35M (+8.38%) | -19.70M (+21.23%) | -16.25M (-29.90%) | -23.18M (+39.05%) | -16.67M (-19.74%) | -20.77M (+40.15%) | -14.82M (+28.76%) | -11.51M (+41.75%) | -8.12M |
Net Income | -9.53M | 10M | -16.29M (+2.84%) | -15.84M (+19.46%) | -13.26M (+1.30%) | -13.09M (-6.63%) | -14.02M (+0.72%) | -13.92M (-19.07%) | -17.20M (-2.55%) | -17.65M (+5.37%) | -16.75M (-13.44%) | -19.35M (-14.57%) | -22.65M (+0.80%) | -22.47M (+13.54%) | -19.79M (-19.59%) | -24.61M (+15.27%) | -21.35M (+8.38%) | -19.70M (+21.23%) | -16.25M (-29.90%) | -23.18M (+39.05%) | -16.67M (-19.74%) | -20.77M (+40.15%) | -14.82M (+28.76%) | -11.51M (+41.75%) | -8.12M |
Comprehensive Income Net Of Tax | -9.53M (-72.80%) | -35.04M (+115.10%) | -16.29M (+2.84%) | -15.84M (+19.46%) | -13.26M (-77.23%) | -58.24M (+315.41%) | -14.02M (+0.72%) | -13.92M (-19.07%) | -17.20M (-77.49%) | -76.40M (+356.12%) | -16.75M (-13.44%) | -19.35M (-14.57%) | -22.65M (-74.33%) | -88.22M (+345.78%) | -19.79M (-19.59%) | -24.61M (+15.27%) | -21.35M (-71.83%) | -75.80M (+366.46%) | -16.25M (-29.90%) | -23.18M (+39.05%) | -16.67M (-69.81%) | -55.22M (+272.60%) | -14.82M | - | - |